Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 27.77%-3M | 49.16%-635K | -31.47%-1.46M | 61.10%-648K | -94.81%-263K | -156.57%-4.16M | -99.20%-1.25M | -7.36%-1.11M | -4,371.79%-1.67M | -135K |
| Net income from continuing operations | -642.63%-261.94M | -10,391.50%-218.54M | 191.59%12.1M | -256.67%-34.9M | -102.14%-20.6M | -38.38%-35.27M | 65.32%-2.08M | -185.21%-13.21M | -86.38%-9.79M | -6.17%-10.19M |
| Operating gains losses | 108.53%28.47M | ---- | ---- | ---- | 62.62%7.51M | 806.04%13.65M | -485.66%-4.33M | 445.43%6.42M | 299.28%1.95M | 43.51%4.62M |
| Remuneration paid in stock | --19.46M | --3.3M | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cashItems | 1,330.99%203.64M | 1,382.40%182.26M | -224.54%-13.95M | 88.11%23.27M | 147.42%12.07M | -23.73%14.23M | -528.46%-14.21M | 139.05%11.2M | 136.80%12.37M | -10.25%4.88M |
| Change In working capital | 128.10%7.36M | 178.30%3.87M | -57.24%387K | 534.15%2.34M | 35.59%762K | 26.44%3.23M | 48.09%1.39M | 340.05%905K | -64.59%369K | -40.72%562K |
| -Change in receivables | --6K | --11K | ---4K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in prepaid assets | ---50K | ---7K | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in payables and accrued expense | 129.46%7.41M | 178.02%3.87M | -56.80%391K | ---- | ---- | --3.23M | --1.39M | --905K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 27.77%-3M | 49.16%-635K | -31.47%-1.46M | 61.10%-648K | -94.81%-263K | -156.57%-4.16M | -99.20%-1.25M | -7.36%-1.11M | -4,371.79%-1.67M | ---135K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -9.02%2.79M | -99.11%1K | 7,579.41%2.61M | -93.33%173K | 0 | -11.99%3.06M | -91.61%112K | -85.02%34K | 35.33%2.59M | 322K |
| Net issuance payments of debt | --1.7M | --0 | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -64.55%1.09M | -99.11%1K | 2,579.41%911K | -93.33%173K | --0 | 1,789.51%3.06M | 51.35%112K | -61.36%34K | --2.59M | --322K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -9.02%2.79M | -99.11%1K | 7,579.41%2.61M | -93.33%173K | --0 | -11.99%3.06M | -91.61%112K | -85.02%34K | 35.33%2.59M | --322K |
| Net cash flow | ||||||||||
| Beginning cash position | -59.13%759K | -38.08%1.17M | -99.29%21K | -75.73%496K | -59.13%759K | --1.86M | 65.01%1.9M | 51.97%2.97M | --2.04M | --1.86M |
| Current changes in cash | 80.05%-219K | 44.24%-634K | 207.26%1.15M | -151.24%-475K | -240.64%-263K | -159.13%-1.1M | -260.59%-1.14M | -33.37%-1.08M | --927K | --187K |
| End cash Position | -28.85%540K | -28.85%540K | -38.08%1.17M | -99.29%21K | -75.73%496K | -59.13%759K | -59.13%759K | 65.01%1.9M | 51.97%2.97M | --2.04M |
| Free cash from | 27.77%-3M | 49.16%-635K | -31.47%-1.46M | 61.10%-648K | -94.81%-263K | -156.57%-4.16M | -99.20%-1.25M | -7.36%-1.11M | -4,371.79%-1.67M | ---135K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.